KEMIFARMA Consulting ApS: Financial statements 2018
CVR: 34709955
Source: annual report 2018, Danish Business Authority
01/01/2018 – 31/12/2018
KEMIFARMA Consulting ApS (CVR 34709955) has filed annual accounts for 2018. In 2018, the company reported a gross profit of DKK -23,431 and a net result of DKK -78,923 compared with DKK 190,546 the year before. Equity in the 2018 report amounted to DKK 2,320,115. The solvency ratio was 99.4%.
- Gross Profit
- DKK -23,431
- Profit/Loss
- DKK -78,923
- Equity
- DKK 2,320,115
- Total Assets
- DKK 2,333,967
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2018 | - | -23K | -79K | 2.3M | - |
| 2017 | - | -11K | 191K | 2.4M | - |
| 2016 | - | -13K | 4K | 2.3M | - |
| 2015 | - | -12K | 352K | 2.3M | - |
| 2014 | - | -10K | 296K | 2M | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2018
KEMIFARMA Consulting ApS has published its annual report for 2017. Gross profit came to DKK -11,388, and the net result was DKK 190,546.
About KEMIFARMA Consulting ApS
KEMIFARMA Consulting ApS is a Danish company of the type Anpartsselskab based in Kgs. Lyngby, founded in 2012. The company is registered under the industry Anden teknisk rådgivning. The company was previously named KEMIFARMA HOLDING ApS. The management consists of Christian Hede-Andersen. The company is owned by Christian Hede-Andersen. The company has 1 employee (2023). In 2025, the company reported a gross profit of DKK -57,469 and a net result of DKK 541,385 compared with DKK -378,700 the year before. Equity in the 2025 report amounted to DKK 3,414,022.